1-10-19.
BAT (Brown
adipose tissue) ::: WAT (White
adipose tissue)
BAT is
recognized as a regulator of whole body energy expenditure and body fat in
humans and a hopeful target combating obesity and related disorders. Unfortunately BAT levels decrease as we age
leading to an increase in weight gain Adipose tissue is a major metabolic organ and it has
been traditionally classified as either white adipose tissue or brown adipose
tissue. WAT and BAT are characterized by different anatomical locations morphological
structures functions and regulations. WAT and BAT are both involved in energy
balance. WAT is mainly involved in the storage and mobilization of energy in
the form of triglycerides. Whereas BAT specializes in dissipating energy as
heat during cold or diet induced thermo genesis.
WAT generally constitutes as much as 20% of the body
weight of normal adult humans. WAT is normally characterized by an ivory or yellowish color as well as
unilocular/large lipid droplets.
By
contrast brown adipose tissue is recognized as the major site of
sympathetically activated no shivering thermo genesis during cold exposure and
after spontaneous hyperphagia thereby controlling whole body energy expenditure
and body fat. Thus BAT
is recognized as a regulator of whole body energy expenditure and body fat in
humans and a hopeful target combating obesity and related disorders. In fact
there are some food ingredients such as capsaicin and capsinoids which have
potential to activate and recruit BAT via activity on the specific receptor
transient receptor potential channels thereby increasing energy expenditure and
decreasing body fat modestly and consistently.
.
Sympathetic nerve activity in adipose tissues is increased in response to cold
exposure and oral ingestion of food ingredients through the activation of
transient receptor potential channels.
.Nor
adrenaline binds to B-adrenergic receptors and initiates signaling cascades for
triglyceride hydrolysis. The released fatty acids activate
uncoupling protein 1 and are oxidized to serve as an energy source of thermo
genesis..Activated
UCP1 uncouples oxidative phosphorylation from ATP synthesis and
dissipates energy as heat. .Chronic sympathetic activation is bad because this
causes not only brown
fat hyperplasia but also an induction of beige cells in white fat
thereby increasing whole body energy expenditure and decreasing body fat.
Formation
of beige/brite adipocytes
White
adipose depots have the ability to switch between energy storage and
expenditure . Thus these depots can shift from a WAT phenotype to a
BAT like phenotype in terms of features such as morphology gene expression pattern and
mitochondrial respiratory activity under some specific stimuli. As mentioned
above this induction of the brown adipocyte like phenotype in WAT is called “browning
“ and the beige/ brite cells of WAT are capable of this transformation. The
beige/brite cells in WAT are derived from precursor cells that are different
from classical brown adipocytes and are closer to the white adipocyte cell
lineage. These beige/brite cells show a white adipocyte like phenotype.
Including large lipid droplets and the lack of UCP1 expression under basal
conditions. However in response to certain stimuli beige/brite cells transform
into cells having BAT like characteristics such as multilocular /small lipid
droplets and UCP1 expression.
Unfortunately BAT
levels decrease as we age leading to an increase in weight gain . Because capsaicinoids can
reactivate BAT into producing energy consumption of capsaicinoids may help individuals maintain
a healthy weight with aging.
A study
concluded that capsinoids ingestion increases EE through the activation of BAT
in humans.
Several
research studies have looked at the impact of capsaicinoids on fat tissue
within the body . Seven trials have found evidence of increased fat utilization
or decreased fat stores. One study found a significant increase in fat
metabolism as measured by a process called lipid oxidation among participants
taking capsaicin supplements for four months.
“Beadlet” Technology
Capsicum
extract loaded onto an inert central core and covered with a special coating
that leaves no exposed capsaicinoids layer. This patented “beadlet “ technology
allows for the active ingredient to be delivered within a capsule without the
problem of gastric discomfort and burning .
Prevalence
Some recent
WHO global estimates follow:
.In 2014 more than 1.9 billion ,18 years and
older were overweight of these over 600 million were obese.
.Overall
about 13% of the world’s adult population was obese in 2014
.In 2014
,39% of adults aged 18 years and over were overweight .
.The
worldwide prevalence of obesity more than doubled between 1980 and 2014.In
India states which topped the lists of rates of obesity are Punjab , Kerala and
Goa .Though the percentage of obesity in India is less compared to United
states of America and other developed countries , it is significant due to
sheer size of population . Indians are genetically susceptible to weight
accumulation especially around the waist.
In 2013 ,42
million children under the age of 5 were overweight or obese. Once considered a
high income country problem overweight and obesity are now on the rise in low and middle
income countries particularly in urban settings. In developing countries with
emerging economies the rate of increase of childhood overweight and obesity has
been more than 30% higher than that of developed countries.Overweight and
obesity are linked to more deaths worldwide than underweight. Most of the
world’s population live in countries where overweight and obesity kill more
people than underweight .
Pathophysiology of obesity
.The
afferent system generates humoral signals from adipose tissue pancreas and
stomach
.Acting in
the brain leptin and to a lesser extent insulin decrease food intake and
increase energy expenditure promoting weight loss. They are consequently termed
catabolic adiposity signals.
.Impinging
on the same neuronal targets ghrelin exerts opposite effects and is thus an
anabolic hormone.
.The amount
of leptin is direct proportion to
adipose stores. Weight gain evokes proportionate increases in catabolic
hormones and decreases ghrelin whereas weight loss causes the opposite.
1 Afferent
system generates signals released fro adipose tissue pancreas and stomach.
2 Central
processing unit present in hypothalamus having two set of neurons: orexigenic
and anorexigenic neurons
3 Efferent
system carries out anabolic and catabolic signals by modulating feeding
behavior or energy expenditure.
APY/AgRP
=NeuropeptideY/Agouti related peptide;
POMC/CART= Pro- opiomelanocortin/cocaine and
Amphetamine Related Transcript
NPY
Rec=Neuropeptide receptor; MCH = Melanin Concentrating Hormone
MSH =
Melanocyte stimulating hormone; Mc4R=Melanocortin receptor
TRH=Thyrotrophin
releasing hormone ;CRH=Corticotrophic Releasing hormone.
Cardiovascular
Disease
Obesity is
an independent risk factor for CVD as including CHD myocardial infarction
angina pectoris congestive hear failure stroke hypertension and atrial
fibrillation. Overall results from large prospective and observational studies
confirm the marked adverse effects of obesity on CVD.Intima media thickness a
noninvasive marker for early atherosclerotic changes was found to be
significantly increased in the obese children as compared with nonobese
children of similar age sex and pubertal stage.Not only is obesity linked with
hypertension but weight loss in obese subjects is associated with a decline in
blood pressure. The anti hypertensive effect of weight loss is independent of
race or gender . Furthermore chronic
obesity reduces the efficacy of antihypertensive medication.
Bad fat turnover as man ages :-: Unfortunately BAT levels
decrease as we age leading to an increase in weight gain . Because
capsaicinoids can reactivate BAT into producing energy consumption of
capsaicinoids may help individuals maintain a healthy weight with aging. Coming
to Obesity and Reproductive Health the followings are relevant :-
Obesity during pregnancy is associated with an
increased risk of complications including gestational diabetes pre -eclampsia and delivery
complications such as macrosomia shoulder dystocia and higher rates oc
caesarean sections and infections, Obesity is now estimated to be responsible
for 6% of primary infertility. Obesity and insulin resistance are closely
related with PCOS and insulin resistance has a pivotal role in the pathogenesis
of this syndrome. Body weight and body fats are considered to be significant
physiological triggers of menarche. Hence obese girls often present with
menarche before the age of 10 years.
In men there
is a link between impotence and increasing infertility with abdominal obesity a
particular risk.
Obesity in
men can result in both physical changes and hormonal changes. These changes in
turn contribute to oligozoospermia azoospermia an increase in the DFi and a
decrease in semen volume.
Available
data suggest that a little as 5%-10% weight loss can improve fertility
outcomes.
Dyslipidemia
Obesity is
associated with an unfavorable lipid profile . Lipid abnormalities related to
obesity include an elevated serum concentration of cholesterol low density
lipoprotein cholesterol very low density lipoprotein cholesterol triglycerides
and apo lipoprotein B, as well as a reduction in serum high density lipoprotein
cholesterol . Insulin resistance and hyperinsulinaemia stimulating hepatic
triglyceride synthesis from an increased adipose tissue undergoing enhanced
lipolysis. This leads to postprandial hypertriglyceridemia smaller and denser
LDL particles and reduced HDL cholesterol concentrations.
Dyslipidemia
associated with obesity no doubt plays a major role in the development of
atherosclerosis and CVD a life threatening diseases in obese individuals.
Lifestyle
modifications weight loss exercise dietary fibers and with weight loss
medications can improve this dyslipidemia reducing CVD risk.
Management
of obesity
Obesity
results from a prolonged small positive energy imbalance and treatment needs to
reverse this imbalance. The relationship between energy intake and expenditure
is shown in
Appropriate
goals of weight management emphasize realistic weight loss to achieves a
reduction in health risks and should include promotion of weight loss;
maintenance and prevention of weight regain.
Many
different diets have been tried to treat obesity and weight loss occurs with
all of them. The principal effect seems to be the degree of adherence to the
prescribed calorie reduction.
Obesity
drugs have been developed that tap brain mechanisms for controlling feeding and
the gastrointestinal tract and its peptides.
One of the
key messages for obese patients is that when caloric intake is reduced below
that needed for daily energy expenditure ; there is a predictable rate of
weight loss.
Patients
should understand that since obesity is a chronic disease weight management
will need to be lifelong.
No comments:
Post a Comment